Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity

Nature Immunology

Volumn 7, Issue 1, 2006, Pages 33-39

  Fenner, Jennifer E ^a   Starr, Robyn ^b,d   Cornish, Ann L ^b,e   Zhang, Jian Guo ^b   Metcalf, Donald ^b   Schreiber, Robert D ^c   Sheehan, Kathleen ^c   Hilton, Douglas J ^b   Alexander, Warren S ^b   Hertzog, Paul J ^a  

^a MONASH UNIVERSITY   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c WASHINGTON UNIVERSITY   (United States)

^d ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; INTERFERON RECEPTOR; STAT1 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EMBRYO; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOBLOTTING; IN VIVO STUDY; INNATE IMMUNITY; MOLECULAR INTERACTION; MOLECULAR MECHANICS; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VIRUS INFECTION; VIRUS REPLICATION; VIRUS RESISTANCE;

ANIMALS; ANIMALS, NEWBORN; BLOTTING, SOUTHERN; CARRIER PROTEINS; IMMUNOPRECIPITATION; INTERFERON TYPE I; MEMBRANE PROTEINS; MICE; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, INTERFERON; REPRESSOR PROTEINS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSFECTION; VIRUS DISEASES;

EID: 29244442569     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1287     Document Type: Article

References (52)

1. Gutterman, J.U. Cytokine therapeutics: Lessons from interferon-α. Proc. Natl. Acad. Sci. USA 91, 1198-1205 (1994).
2. Issac, A. & Lindemann, J. Virus interference I: The interferons. Proc. Royal Soc. Lond. B 147, 258-267 (1957).
3. Pestka, S., Langer, J.A., Zoon, K.C. & Samuel, C.E. Interferons and their actions. Annu. Rev. Biochem. 56, 727-777 (1987).
4. Hertzog, P.J, et al. A gene on human chromosome 21 located in the region 21q22.2 to 22q22.3 encodes a factor necessary for signal transduction and antiviral response to type I interferons. J. Biol. Chem. 269, 14088-14093 (1994).
5. Weissmann, C. & Weber, H. The interferon genes. Prog. Nucleic Acid Res. Mol. Biol. 33, 251-300 (1986).
6. Oritani, K., Kincade, P.W., Zhang, C., Tomiyama, Y. & Matsuzuma, Y. Type I interferons and limitin: A comparison of structures, receptors and functions. Cytokine Growth Factor Rev. 12, 337-348 (2001).
7. Le Bon, A. et al. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 14, 461-470 (2001).
8. Bach, E.A., Aguet, M. & Schreiber, R.D. The IFN-γ receptor: A paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15, 563-591 (1997).
9. Godfrey, D.I., Hammond K.J.. Poulton, L.D., Smythe, M.J. & Baxter, A.G. NKT cells: Facts, functions and fallacies. Immunol. Today 21, 573-583 (2000).
10. Darnell,J.E., Kerr, I.M. & Stark, G,R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421 (1994).
11. Stark, G.R., Kerr, I.M,, Williams, B.R., Silverman, R.H. & Schreiber, R.D., How cells respond to interferons. Annu. Rev. Biochem. 67, 227-264 (1998).
12. Gresser, I. How does interferon inhibit tumour growth? Phil. Trans. R. Soc. Lond. B 299, 69-76 (1982).
13. Neel, B.G, Role of phosphatases in lymphocyte activation. Curr. Opin. Immunol. 9, 405-420 (1997).
14. Irie-Sasaki, J. et al. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signaling. Nature 409, 349-354 (2001).
15. Starr, R, et al. A family of cytokine-inducible inhibitors of signaling. Nature 387, 917-921 (1997).
16. Endo, T.A. et al. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387, 921-924 (1997).
17. Naka. T. et al. Structure and function of a new STAT-induced STAT inhibitor. Nature 387, 924-929 (1997).
18. Yoshimura, A. et al. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin-3 and erythropoietin receptors. EMBO J. 14, 2816-2826 (1995).
19. Hilton, D.J. et al. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc. Natl. Acad. Sci. USA 95, 114-119 (1998).
20. Nicholson, S.E. et al. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction, EMBO J. 18, 375-385 (1999).
21. Sasaki, A. et al. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Genes Cells 4, 339-351 (1999).
22. Zhang, J.-G. et al. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc. Natl. Acad. Sci. USA 96, 2071-2076 (1999).
23. Nicholson, S.E. et al. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. Proc. Natl. Acad. Sci. USA 97. 6493-6498 (2000).
24. Yasukawa, H. et al. The JAK binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J. 18, 1309-1320 (1999).
25. Kile, B.T. et al. The SOCS box: A tale of destruction and degradation. Trends Biochem. Sci. 27, 235-241 (2002).
26. Adams, T.E. et al. Growth hormone preferentially induces the rapid, transient expression of SOCS3, a novel inhibitor of cytokine signaling. J. Biol. Chem. 273, 1285-1287 (1998).
27. Sakamoto, H. et al. A Janus kinase inhibitor, JAB, is an interferon-γ inducible gene and confers resistance to interferons. Blood 92, 1668-1676 (1998).
28. Bjorbaek, C., Elmquist, J.K., Frantz, J.D., Shoelson, S.E. & Flier, J.S. Identification of SOCS3 as a potential mediator of central leptin resistance. Mol. Cell 1, 619-625 (1998).
29. Starr, R. et al. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc. Natl. Acad. Sci. USA 95, 14395-14399 (1998).
30. Naka, T. et al. Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. Proc. Natl. Acad. Sci. USA 95, 15577-15582 (1998).
31. Alexander, W.S. et al. SOCS 1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98, 1-20 (1999).
32. Marine, J.C. et al. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell 98, 609-616 (1999).
33. Brysha, M. et al. Suppressor of cytokine signaling 1 attenuates the duration of interferon gamma signal transduction in vitro and in vivo. J. Biol. Chem. 276, 22086-22089 (2001).
34. Hertzog, P.J., Emery, P., Cheetham, B.F., Mackay, I.R. & Linnane, A.W. Interferons in rheumatoid arthritis: Alterations in production and response related to disease activity. Clin. Immunol. Immunopathol. 48, 192-201 (1988).
35. Song, M.M. & Shuai, K. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities. J. Biol. Chem. 273, 35056-35062 (1998).
36. Kubo, M., Hanada, T. & Yoshimura, A. Suppressors of cytokine signaling and immunity. Nat. Immunol. 4, 1169-1176 (2003).
37. Bullen, D.V., Darwiche, R., Metcalf, D., Handman, E. & Alexander, W.S. Neutralisation of interferon-γ in neonatal Socs1 mice prevents fatty degeneration of the liver but not subsequent fatal inflammatory disease. Immunology 104, 92-98 (2001).
38. Metcalf, D., Mifsud, S., Di Rage, L. & Alexander, W.S. The lethal effects of transplantation of Socs1 bone marrow cells into irradiated adult syngeneic recipients. Proc. Natl. Acad. Sci. USA 100, 8436-8441 (2003).
39. Dalton, D.K. et al. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259, 1739-1742 (1993).
40. Biron, C.A. Cytokines in the generation of immune responses to, and resolution of, virus infection. Curr. Opin. Immunol. 6, 530-538 (1994).
41. Müller, U. et al. Functional role of type I and type II interferons in antiviral defense. Science 264, 1918-1921 (1994).
42. Hwang, S.Y. et al. A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons α and β and alters macrophage responses. Proc. Natl. Acad. Sci. USA 92, 11284-11288 (1995).
43. Eyles, J.L., Metcalf, D., Grusby, M.J., Hilton, D.J. & Starr, R. Negative regulation of interleukin-12 signaling by suppressor of cytokine signaling 1. J. Biol. Chem. 277, 43735-43740 (2002).
44. Hamilton, J.A., Whitty, G.A., Kola, I. & Hertzog, P.J. Endogenous IFNα/ β suppresses colony-stimulating factor (CSF) -1-stimulated macrophage DNA synthesis and mediates inhibitory effects of lipopolysaccharide and TNFα. J. Immunol. 156, 2553-2557 (1996).
45. Hertzog, P.J., O'Neill, L.A. & Hamilton, J.A. The interferon in TLR signaling: More than just antiviral. Trends Immunol. 24, 534-539 (2003).
46. Takaoka, A. et al. Cross talk between interferon-γ and -α/β signaling components in caveolar membrane domains. Science 288, 2357-2360 (2000).
47. Cornish, A.L. et al. Suppressor of cytokine signaling-1 regulates signaling in response to interleukin-2 and other γc-dependent cytokines in peripheral T cells. J. Biol. Chem. 278, 22755-22761 (2003).
48. + T cell differentiation. Immunity 18, 475-487 (2003).
49. Sweet, M.J. et al. A novel pathway regulating lipopolysaccharide-Induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J. Immunol. 166, 6633-6639 (2001).
50. Hertzog, P.J. Isolation of embryonic fibroblasts and their use in the in vitro characterization of gene function. Methods Mol. Biol. 158, 205-215 (2001).
51. Dunn, G.P. et al. A critical function for type I interferons in cancer immunoediting. Nat. Immunol. 6, 722-729 (2005).
52. Wilson-Annon, J. et al. Proapoptotic BH3-only proteins trigger membrane integration of prosurvival Bcl-w and neutralize its activity. J. Cell. Biol. 162, 877-887 (2003).